We are live on ! Find out more
GMED icon

Globus Medical

408 hedge funds and large institutions have $5.72B invested in Globus Medical in 2023 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 132 increasing their positions, 164 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $3.61M

11% more funds holding in top 10

Funds holding in top 10: 910 (+1)

5% more capital invested

Capital invested by funds: $5.43B → $5.72B (+$289M)

0.15% less ownership

Funds ownership: 93.23%93.09% (-0.15%)

5% less funds holding

Funds holding: 431408 (-23)

20% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 164

22% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 65

Holders
408
Holders Change
-23
Holders Change %
-5.34%
% of All Funds
5.95%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.15%
New
51
Increased
132
Reduced
164
Closed
65
Calls
$26.2M
Puts
$3.61M
Net Calls
+$22.6M
Net Calls Change
+$12.3M
Name Holding Trade Value Shares
Change
Change in
Stake
ProShare Advisors
276
ProShare Advisors
Maryland
$339K -$5.85K -120 -2%
Simplex Trading
277
Simplex Trading
Illinois
$338K +$310K +6,357 New
RFC
278
Regions Financial Corp
Alabama
$327K -$26.2K -538 -8%
HF
279
HRT Financial
New York
$326K -$2.08M -42,596 -87%
CCM
280
Coldstream Capital Management
Washington
$323K +$94.5K +1,939 +47%
Cerity Partners
281
Cerity Partners
New York
$320K +$293K +6,010 New
HI
282
Handelsinvest Investeringsforvaltning
Denmark
$303K +$277K +5,682 New
JIC
283
Johnson Investment Counsel
Ohio
$300K -$127K -2,616 -32%
HA
284
Hanover Advisors
South Carolina
$297K +$272K +5,580 New
BPCE
285
Bank Pictet & Cie (Europe)
Germany
$292K -$10.3K -211 -4%
Verition Fund Management
286
Verition Fund Management
Connecticut
$291K -$2.38M -48,797 -90%
Fifth Third Bancorp
287
Fifth Third Bancorp
Ohio
$290K -$167K -3,422 -39%
MFIM
288
Mesirow Financial Investment Management
Illinois
$285K +$261K +5,352 New
HWAM
289
Hennion & Walsh Asset Management
New Jersey
$284K -$1.85K -38 -0.7%
Creative Planning
290
Creative Planning
Kansas
$268K -$61.5K -1,261 -20%
SGA
291
Seaport Global Advisors
Massachusetts
$258K
GT
292
Greenleaf Trust
Michigan
$248K +$227K +4,653 New
NSEDCP
293
NJ State Employees Deferred Compensation Plan
New Jersey
$240K
DC
294
Diametric Capital
Massachusetts
$237K -$940K -19,292 -81%
US Bancorp
295
US Bancorp
Minnesota
$226K -$29.6K -607 -13%
MML Investors Services
296
MML Investors Services
Massachusetts
$225K +$206K +4,228 New
FBC
297
Fairfield, Bush & Co
Connecticut
$223K
Wealth Enhancement Advisory Services
298
Wealth Enhancement Advisory Services
Minnesota
$223K -$21.8K -447 -10%
MM
299
MQS Management
New York
$218K +$199K +4,089 New
SCM
300
Shelton Capital Management
Colorado
$210K +$192K +3,944 New

GMED Hedge Fund Activity: Q4 2023 in Review

408 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2023, worth a combined $5.72B — up 5.3% from $5.43B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of GMED and 51 opened new positions — a net loss of 14 holders — while 164 trimmed existing stakes and 132 added.

The largest buyer was Millennium Management, adding an estimated $80.5M. The largest seller was Nuance Investments, exiting entirely with an estimated $180M sold.

  • 408 institutional investors held Globus Medical (GMED) as of Q4 2023, down from 431 in Q3 2023.
  • Funds reported $5.72B of Globus Medical stock for Q4 2023, up 5.3% quarter-over-quarter.
  • 51 funds opened new Globus Medical positions in Q4 2023 and 65 closed out, a net change of -14 holders.
  • The largest Globus Medical buyer in Q4 2023 was Millennium Management, an estimated $80.5M added.
  • The largest Globus Medical seller in Q4 2023 was Nuance Investments, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2023.